Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shear Stress and Microbubble-Mediated Modulation of Endothelial Cell Immunobiology. | Small Sci | 2025 | 40657183 | PubTator, text mining | PubMed |
| The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapy. | Genome Med | 2025 | 40588764 | PubTator, text mining | PubMed |
| Early diagnosis of acute myocardial infarction via hub genes identified by integrated weighted gene co-expression network analysis. | Am Heart J Plus | 2025 | 40575177 | PubTator, text mining | PubMed |
| Exploration of plasma factor profiles involved in tumor growth factors in non-small cell carcinoma patients with interstitial pneumonia. | Respir Investig | 2025 | 40570814 | PubTator, text mining | PubMed |
| Individualized diagnosis of rheumatoid arthritis: A rank-based qualitative T cell-related signature. | PLoS One | 2025 | 40569958 | PubTator, text mining | PubMed |
| Research progress on the regulation of autophagy in cardiovascular diseases by chemokines. | Open Life Sci | 2025 | 40535169 | PubTator, text mining | PubMed |
| SOAR elucidates biological insights and empowers drug discovery through spatial transcriptomics. | Sci Adv | 2025 | 40498826 | PubTator, text mining | PubMed |
| The role of CXCL16 in atherosclerosis: from mechanisms to therapy. | Front Immunol | 2025 | 40491927 | PubTator, text mining | PubMed |
| A novel Tc17 population recruited by tumor cells promotes tumor progression in gastric cancer. | Front Oncol | 2025 | 40452847 | PubTator, text mining | PubMed |
| An emerging paradigm of CXCL16 involvement in cancer progression. | Cytokine Growth Factor Rev | 2025 | 40442011 | PubTator, text mining | PubMed |
| 17β-Estradiol Promotes Tumorigenicity Through an Autocrine AREG/EGFR Loop in ER-α-Positive Breast Cancer Cells. | Cells | 2025 | 40422206 | PubTator, text mining | PubMed |
| Synthetic Biology-Based Engineering Cells for Drug Delivery. | Exploration (Beijing) | 2025 | 40395752 | PubTator, text mining | PubMed |
| Decoding the impact of MMP1+ malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics. | Cell Death Discov | 2025 | 40394037 | PubTator, text mining | PubMed |
| Characterization and prognostic of CD8 + TIM3 + CD101 + T cells in glioblastoma multiforme. | Cell Biosci | 2025 | 40375334 | PubTator, text mining | PubMed |
| Platelets and diseases: signal transduction and advances in targeted therapy. | Signal Transduct Target Ther | 2025 | 40374650 | PubTator, text mining | PubMed |
| Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer. | Front Pharmacol | 2025 | 40371356 | PubTator, text mining | PubMed |
| Engineered bacteria assist CAR-cell immunotherapy. | Acta Pharm Sin B | 2025 | 40370556 | PubTator, text mining | PubMed |
Comprehensive single-cell transcriptomic reveals different destinies of melanocytes and dynamic changes of immune microenvironment in a psychological stress-induced leukoderma and leukotrichia mouse model. | Mol Med | 2025 | 40361040 | PubTator, text mining | PubMed |
| High metastatic tumor-derived CXCL16 mediates liver colonization metastasis by inducing Kupffer cell polarization via the PI3K/AKT/FOXO3a pathway. | Neoplasia | 2025 | 40347803 | PubTator, text mining | PubMed |
| Metabolic reprogramming through histone lactylation in microglia and macrophages recruits CD8+ T lymphocytes and aggravates spinal cord injury. | Neuron | 2025 | 40328251 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=9